Evidence map›Paper›PMID 36675752›Full record

ReviewJournal of personalized medicine2022

Genetic Approaches for the Treatment of Giant Axonal Neuropathy.

Satomi Shirakaki, Rohini Roy Roshmi, Toshifumi Yokota

Open access · goldAbstract readReview
In one paragraph

Review in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Autism candidate genebioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Satomi ShirakakiDepartment of Medical Genetics, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Rohini Roy RoshmiDepartment of Medical Genetics, University of Alberta, Edmonton, AB T6G 2H7, Canada.
Toshifumi YokotaDepartment of Medical Genetics, University of Alberta, Edmonton, AB T6G 2H7, Canada.ORCID 0000-0001-6672-6742
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant axonal neuropathy (GAN) is a pediatric, hereditary, neurodegenerative disorder that affects both the central and peripheral nervous systems. It is caused by mutations in the

Indexed as

AAV9autophagyaxonGANgene therapygigaxoninubiquitin-proteosome system

Identifiers

PMID36675752
PMCPMC9865904
OpenAlexW4313316813

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.